Medical Science Liaison (Cardio)
|
 |
Location: |
Dublin
|
 |
 |
Qualifications: |
PhD |
 |
 |
Experience: |
2-3 Years |
 |
 |
Job Type: |
Permanent
|
 |
 |
Salary: |
Negotiable |
 |
 |
Consultant: |
Eamonn O'Raghallaigh |
|
|
Medical Science Liaison (Cardio)
|
Medical Science Liaison Executive (Cardiovascular)
My client is a leading multinational pharmaceutical company with a strong track record and reputation globally. They are seeking a Medical Science Liaison Executive to join the team with a specific focus on their elements of their cardiovascular product range.
Purpose: The MSL will act as the national scientific expert in the cardiovascular area. Engage health care professionals and KOL’s in high quality peer to peer scientific and clinical exchange. Heighten understanding of product and therapy science internally and externally and share knowledge and insight with cross-functional colleagues. Create a field extension of the scientific information service, working proactively and predominantly in the field.
Key Tasks: 1. KOL Interaction and Engagement (60%) (a) Participate in Market Preparation and Access - Target KOL’s to provide insight into product positioning while establishing credibility in peer to peer relationships - Identify advocates and potential speakers and targets for post-launch education and training - Identify potential high volume prescribers and clarify targets - Identify opportunities and blockers to the product uptake prior to launch such as adherence/adoption of protocols - providing medical support when further information is requested - gather critical insight that may help facilitate decision making and planning - Liaise with decision makers and influencers to provide scientific exchange and budget impact information in advance of product availability - Undertake formulary presentations
(b) Attend relevant scientific congresses to gather contextualised new company and competitor information through session attendance and Health Care Professional (HCP) meetings & to build relationships with KOLs.
(c) Respond to requests by HCPs for information about development compounds and clinical/ scientific data relating to currently marketed products in line with industry and company Medical Information & standards and IPHA Code of Marketing. Where necessary, liaise with medical information colleagues to ensure most appropriate response (face to face or letter)
(d) Liaise with national and regional opinion leaders, investigators and potential investigators on a two-way scientific communication about: - current clinical practice and treatment pathways - company clinical development programmes, study ideas & feasibility - positioning, use and experience of current marketed compounds - Support educational initiatives in the specialty - This will be done through individual, group and advisory board interaction. All discussions should be high quality technical and scientific exchanges in line with company standards and IPHA Code of Marketing
(e) Share opinions and insight gathered with relevant Medical Dept., marketing, research and sales colleagues as appropriate
(f) Maintain relationships with advocates and KOLs post-launch
2. Therapy area and compliance framework knowledge (20%)
(g) Responsible for remaining up-to-date on therapy advances, product development plans, competitor developments and trials, company products and trial data (h) Maintain an open dialogue with office-based Medical colleagues to ensure consistency of information being provided to HCPs (i) Share educational highlights and insight gathered while at scientific congress with colleagues (j) Responsible for remaining up to date on IPHA code changes, and impact on ways of working (k) Work according to local and global SOPs, maintaining personal training records (l) Liaise with MSL/Medical colleagues in UK and Europe to ensure up to date knowledge of data and strategy
3. Internal customer interactions (15%) (m) Provide reactive medical input for local account management plans and KOL development plans including TAPs (n) Maintain dialogue with local sales team to ensure customer needs are established and met (o) Provide insight and input into Hospital formulary activities, supporting formulary submissions if applicable (p) Support Regulatory through ongoing engagement with sales teams re: risk minimisation tracking
4. Generate phase IV clinical plans (5%)
(q) Produce and maintain a database of potential investigators as required for specific trials, including information on market impact of study centres (r) Ensure potential investigators are fully aware of the selection criteria used by the company to place research grants and manage investigators expectations accordingly
Qualifications & Skills
Essential PhD in Life Sciences, BSc (Pharmacy) or MB/MD Specialist Interest/Knowledge in Cardiovascular Pharmacology Excellent communication and presentation skills Proven ability to understand, assimilate and communicate scientific information Understanding of IPHA Code of Practice and its practical application Proven ability to develop relationships with key thought leaders or investigators Proven ability to work in a team Chairing and facilitation skills Ability to understand commercial development perspectives Based in Dublin, but willingness to travel throughout Ireland and occasionally transnationally
Desirable Experience in the development of clinical trial programmes in the support of the therapy area portfolio an advantage
For Immediate consideration please apply online or if you would like to discuss this opportunity further please contact: Eamonn O’Raghallaigh MSc on (01) 685 48 48 or email eor [at] lifescience [dot] ie
Your data will be treated in the strictest confidence in accordance with the Data Protection Acts 1988 and 2003.
|
|
|
|
|
|